{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:43:52Z","timestamp":1793598232848,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Joint Funds for the Innovation of Science and Technology of Fujian Province","award":["2021Y9123"],"award-info":[{"award-number":["2021Y9123"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology of Fujian Province","award":["2023Y9107"],"award-info":[{"award-number":["2023Y9107"]}]},{"name":"Fujian Provincial Health and Wellness Science and Technology Project","award":["2025QNB012"],"award-info":[{"award-number":["2025QNB012"]}]},{"name":"the Fujian Provincial Health and Family Planning Commission","award":["2021ZQNZD005"],"award-info":[{"award-number":["2021ZQNZD005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12140-y","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:39:20Z","timestamp":1781876360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The bile acid-oxysterol axis in pulmonary arterial hypertension: from sterol trafficking to precision phenotyping and therapeutic opportunities"],"prefix":"10.1007","volume":"53","author":[{"given":"Shuwei","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajun","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"12140_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-physiol-031620-123956","volume":"83","author":"W Xu","year":"2021","unstructured":"Xu W, Janocha AJ, Erzurum SC (2021) Metabolism in pulmonary hypertension. Annu Rev Physiol 83:551\u2013576. https:\/\/doi.org\/10.1146\/annurev-physiol-031620-123956","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"12140_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/biomedicines9010057","volume":"9","author":"K Kurakula","year":"2021","unstructured":"Kurakula K, Smolders VFED, Tura-Ceide O, Jukema JW, Quax PHA, Goumans MJ (2021) Endothelial dysfunction in pulmonary hypertension: cause or consequence? Biomedicines 9(1):57. https:\/\/doi.org\/10.3390\/biomedicines9010057","journal-title":"Biomedicines"},{"issue":"1","key":"12140_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman JS, Kumar S (2024) Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target therapy 9(1):97. https:\/\/doi.org\/10.1038\/s41392-024-01811-6","journal-title":"Signal Transduct Target therapy"},{"issue":"3","key":"12140_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mam.2009.02.002","volume":"30","author":"D T\u00f6r\u00f6csik","year":"2009","unstructured":"T\u00f6r\u00f6csik D, Szanto A, Nagy L (2009) Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages. Mol Aspects Med 30(3):134\u2013152. https:\/\/doi.org\/10.1016\/j.mam.2009.02.002","journal-title":"Mol Aspects Med"},{"issue":"7","key":"12140_CR5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/biomedicines13071637","volume":"13","author":"R Wawrzyniak","year":"2025","unstructured":"Wawrzyniak R, Gaillard T, Biesemans M, Zi\u0119ba B, Lewicka E, Markuszewski M, D\u0105browska-Kugacka A (2025) Plasma multiplatform metabolomics towards evaluation of gender differences in pulmonary arterial hypertension-a pilot study. Biomedicines 13(7):1637. https:\/\/doi.org\/10.3390\/biomedicines13071637","journal-title":"Biomedicines"},{"issue":"6","key":"12140_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s11306-014-0653-y","volume":"10","author":"YD Zhao","year":"2014","unstructured":"Zhao YD, Yun HZH, Peng J, Yin L, Chu L, Wu L, Michalek R, Liu M, Keshavjee S, Waddell T, Granton J, de Perrot M (2014) De novo synthesize of bile acids in pulmonary arterial hypertension lung. Metabolomics: Official J Metabolomic Soc 10(6):1169\u20131175. https:\/\/doi.org\/10.1007\/s11306-014-0653-y","journal-title":"Metabolomics: Official J Metabolomic Soc"},{"issue":"5","key":"12140_CR7","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1161\/CIRCULATIONAHA.116.024602","volume":"135","author":"CJ Rhodes","year":"2017","unstructured":"Rhodes CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, Hadinnapola C, Watson G, Bleda M, Haimel M, Coghlan G, Corris PA, Howard LS, Kiely DG, Peacock AJ, Pepke-Zaba J, Toshner MR, Wort SJ, Gibbs JS, Lawrie A, Gr\u00e4f S, Morrell NW, Wilkins MR (2017) Plasma metabolomics implicates modified transfer rnas and altered bioenergetics in the outcomes of pulmonary arterial hypertension. Circulation 135(5):460\u2013475. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024602","journal-title":"Circulation"},{"key":"12140_CR8","doi-asserted-by":"publisher","first-page":"eadn7277","DOI":"10.1126\/science.adn7277","volume-title":"Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension","author":"LD Harvey","year":"2025","unstructured":"Harvey LD, Alotaibi M, Tai YY, Tang Y, Kim HJ, Kelly NJ, Sun W, Woodcock CC, Arshad S, Culley MK, El Khoury W, Xie R, Aaraj A, Zhao Y, Hafeez J, Rao N, Jiang RJ, Negi S, Kirillova V, Perk A, Chan D, S. Y (2025) Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension, vol 387. Science, New York, N.Y.), p eadn7277. 6732https:\/\/doi.org\/10.1126\/science.adn7277"},{"key":"12140_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S (2019) SANRA-a scale for the quality assessment of narrative review articles. Res Integr peer Rev 4:5. https:\/\/doi.org\/10.1186\/s41073-019-0064-8","journal-title":"Res Integr peer Rev"},{"issue":"6","key":"12140_CR10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1124\/pharmrev.124.000978","volume":"76","author":"T Li","year":"2024","unstructured":"Li T, Chiang JYL (2024) Bile Acid signaling in metabolic and inflammatory diseases and drug development. Pharmacol Rev 76(6):1221\u20131253. https:\/\/doi.org\/10.1124\/pharmrev.124.000978","journal-title":"Pharmacol Rev"},{"key":"12140_CR11","doi-asserted-by":"publisher","first-page":"108238","DOI":"10.1016\/j.pharmthera.2022.108238","volume":"237","author":"J Cai","year":"2022","unstructured":"Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD (2022) Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther 237:108238. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108238","journal-title":"Pharmacol Ther"},{"key":"12140_CR12","doi-asserted-by":"publisher","first-page":"723224","DOI":"10.3389\/fphys.2021.723224","volume":"12","author":"WJ Griffiths","year":"2021","unstructured":"Griffiths WJ, Wang Y (2021) Sterols, oxysterols, and accessible cholesterol: signaling for homeostasis, in immunity and during development. Front Physiol 12:723224. https:\/\/doi.org\/10.3389\/fphys.2021.723224","journal-title":"Front Physiol"},{"issue":"1","key":"12140_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20230934","volume":"138","author":"CCJ Groenen","year":"2024","unstructured":"Groenen CCJ, Nguyen TA, Paulusma CC, van de Graaf SFJ (2024) Bile salt signaling and bile salt-based therapies in cardiometabolic disease. Clin Sci (London England: 1979) 138(1):1\u201321. https:\/\/doi.org\/10.1042\/CS20230934","journal-title":"Clin Sci (London England: 1979)"},{"issue":"1","key":"12140_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12931-024-02775-5","volume":"25","author":"H Ba","year":"2024","unstructured":"Ba H, Guo Y, Jiang Y, Li Y, Dai X, Liu Y, Li X (2024) Unveiling the metabolic landscape of pulmonary hypertension: insights from metabolomics. Respir Res 25(1):221. https:\/\/doi.org\/10.1186\/s12931-024-02775-5","journal-title":"Respir Res"},{"issue":"4","key":"12140_CR15","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1111\/jcmm.14937","volume":"24","author":"C Chen","year":"2020","unstructured":"Chen C, Luo F, Wu P, Huang Y, Das A, Chen S, Chen J, Hu X, Li F, Fang Z, Zhou S (2020) Metabolomics reveals metabolite changes of patients with pulmonary arterial hypertension in China. J Cell Mol Med 24(4):2484\u20132496. https:\/\/doi.org\/10.1111\/jcmm.14937","journal-title":"J Cell Mol Med"},{"issue":"3","key":"12140_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1161\/CIRCRESAHA.122.321923","volume":"132","author":"H Pi","year":"2023","unstructured":"Pi H, Xia L, Ralph DD, Rayner SG, Shojaie A, Leary PJ, Gharib SA (2023) Metabolomic Signatures associated with pulmonary arterial hypertension outcomes. Circul Res 132(3):254\u2013266. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321923","journal-title":"Circul Res"},{"issue":"8","key":"12140_CR17","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1021\/acs.jproteome.3c00255","volume":"23","author":"R Wawrzyniak","year":"2024","unstructured":"Wawrzyniak R, Gre\u0161ner P, Lewicka E, Macioszek S, Furga A, Zieba B, Markuszewski J, M., Browska-Kugacka D, A (2024) Metabolomics meets clinics: a multivariate analysis of plasma and urine metabolic signatures in pulmonary arterial hypertension. J Proteome Res 23(8):2795\u20132804. https:\/\/doi.org\/10.1021\/acs.jproteome.3c00255","journal-title":"J Proteome Res"},{"issue":"17","key":"12140_CR18","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1136\/heartjnl-2019-315900","volume":"106","author":"P Chouvarine","year":"2020","unstructured":"Chouvarine P, Giera M, Kastenm\u00fcller G, Artati A, Adamski J, Bertram H, Hansmann G (2020) Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension. Heart 106(17):1332\u20131341. https:\/\/doi.org\/10.1136\/heartjnl-2019-315900","journal-title":"Heart"},{"issue":"13","key":"12140_CR19","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.3390\/molecules30132883","volume":"30","author":"F Brahmi","year":"2025","unstructured":"Brahmi F, Mackrill JJ, Ghzaiel I, Rezig L, Benkhalifa R, Zarrouk A, Jouanny P, Vejux A, Lizard G (2025) Oxysterol-induced inflammation in human diseases: strategies for treatment with natural compounds and synthetic molecules. Molecules 30(13):2883. https:\/\/doi.org\/10.3390\/molecules30132883","journal-title":"Molecules"},{"issue":"1","key":"12140_CR20","doi-asserted-by":"publisher","first-page":"25283","DOI":"10.1038\/s41598-024-76514-7","volume":"14","author":"C Yang","year":"2024","unstructured":"Yang C, Liu YH, Zheng HK (2024) Identification of metabolic biomarkers in idiopathic pulmonary arterial hypertension using targeted metabolomics and bioinformatics analysis. Sci Rep 14(1):25283. https:\/\/doi.org\/10.1038\/s41598-024-76514-7","journal-title":"Sci Rep"},{"issue":"4","key":"12140_CR21","doi-asserted-by":"publisher","first-page":"204589402110543","DOI":"10.1177\/20458940211054304","volume":"11","author":"NP Nickel","year":"2021","unstructured":"Nickel NP, Galura GM, Zuckerman MJ, Hakim MN, Alkhateeb H, Mukherjee D, Austin ED, Heresi GA (2021) Liver abnormalities in pulmonary arterial hypertension. Pulmonary circulation 11(4):20458940211054304. https:\/\/doi.org\/10.1177\/20458940211054304","journal-title":"Pulmonary circulation"},{"issue":"3","key":"12140_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/cld.573","volume":"8","author":"M Hilscher","year":"2016","unstructured":"Hilscher M, Sanchez W (2016) Congestive hepatopathy. Clin liver disease 8(3):68\u201371. https:\/\/doi.org\/10.1002\/cld.573","journal-title":"Clin liver disease"},{"issue":"21","key":"12140_CR23","doi-asserted-by":"publisher","first-page":"11891","DOI":"10.3390\/ijms222111891","volume":"22","author":"DM Gewehr","year":"2021","unstructured":"Gewehr DM, Giovanini AF, Mattar BA, Agulham AP, Bertoldi AS, Nagashima S, Kubrusly FB, Kubrusly LF (2021) Congestive hepatopathy secondary to right ventricular hypertrophy related to monocrotaline-induced pulmonary arterial hypertension. Int J Mol Sci 22(21):11891. https:\/\/doi.org\/10.3390\/ijms222111891","journal-title":"Int J Mol Sci"},{"issue":"9","key":"12140_CR24","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","volume":"23","author":"CCK Mayerhofer","year":"2017","unstructured":"Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, Aukrust P, Gullestad L, Hov JR, Tr\u00f8seid M (2017) Increased secondary\/primary bile acid ratio in chronic heart failure. J Card Fail 23(9):666\u2013671. https:\/\/doi.org\/10.1016\/j.cardfail.2017.06.007","journal-title":"J Card Fail"},{"key":"12140_CR25","doi-asserted-by":"publisher","unstructured":"Rodor, J., Chen, S. H., Scanlon, J. P., Monteiro, J. P., Caudrillier, A., Sweta, S.,Stewart, K. R., Shmakova, A., Dobie, R., Henderson, B. E. P., Stewart, K., Hadoke,P. W. F., Southwood, M., Moore, S. D., Upton, P. D., Morrell, N. W., Li, Z., Chan,S. Y., Handen, A., Lafyatis, R., \u2026 Baker, A. H. (2022). Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension.Cardiovascular research, 118(11), 2519\u20132534. https:\/\/doi.org\/10.1093\/cvr\/cvab296","DOI":"10.1093\/cvr\/cvab296"},{"issue":"3","key":"12140_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1164\/rccm.202307-1310OC","volume":"210","author":"RM Tuder","year":"2024","unstructured":"Tuder RM, Gandjeva A, Williams S, Kumar S, Kheyfets VO, Hatton-Jones KM, Starr JR, Yun J, Hong J, West NP, Stenmark KR (2024) Digital Spatial profiling identifies distinct molecular signatures of vascular lesions in pulmonary arterial hypertension. Am J Respir Crit Care Med 210(3):329\u2013342. https:\/\/doi.org\/10.1164\/rccm.202307-1310OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"12140_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1164\/rccm.202209-1761OC","volume":"209","author":"S Ferrian","year":"2024","unstructured":"Ferrian S, Cao A, McCaffrey EF, Saito T, Greenwald NF, Nicolls MR, Bruce T, Zamanian RT, Del Rosario P, Rabinovitch M, Angelo M (2024) Single-cell imaging maps inflammatory cell subsets to pulmonary arterial hypertension vasculopathy. Am J Respir Crit Care Med 209(2):206\u2013218. https:\/\/doi.org\/10.1164\/rccm.202209-1761OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"11\u201312","key":"12140_CR28","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00424-016-1899-1","volume":"468","author":"L Vengethasamy","year":"2016","unstructured":"Vengethasamy L, Hautefort A, Tielemans B, Belge C, Perros F, Verleden S, Fadel E, Van Raemdonck D, Delcroix M, Quarck R (2016) BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators. Pflug Arch: Eur J Physiol 468(11\u201312):1969\u20131983. https:\/\/doi.org\/10.1007\/s00424-016-1899-1","journal-title":"Pflug Arch: Eur J Physiol"},{"issue":"1","key":"12140_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1465-9921-12-84","volume":"12","author":"S Majka","year":"2011","unstructured":"Majka S, Hagen M, Blackwell T, Harral J, Johnson JA, Gendron R, Paradis H, Crona D, Loyd JE, Nozik-Grayck E, Stenmark KR, West J (2011) Physiologic and molecular consequences of endothelial Bmpr2 mutation. Respir Res 12(1):84. https:\/\/doi.org\/10.1186\/1465-9921-12-84","journal-title":"Respir Res"},{"issue":"2","key":"12140_CR30","doi-asserted-by":"publisher","first-page":"L187","DOI":"10.1152\/ajplung.00303.2015","volume":"310","author":"KS Awad","year":"2016","unstructured":"Awad KS, Elinoff JM, Wang S, Gairhe S, Ferreyra GA, Cai R, Sun J, Solomon MA, Danner RL (2016) Raf\/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 310(2):L187\u2013L201. https:\/\/doi.org\/10.1152\/ajplung.00303.2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"12140_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1164\/rccm.202203-0490OC","volume":"207","author":"DM Moutsoglou","year":"2023","unstructured":"Moutsoglou DM, Tatah J, Prisco SZ, Prins KW, Staley C, Lopez S, Blake M, Teigen L, Kazmirczak F, Weir EK, Kabage AJ, Guan W, Khoruts A, Thenappan T (2023) Pulmonary arterial hypertension patients have a proinflammatory gut microbiome and altered circulating microbial metabolites. Am J Respir Crit Care Med 207(6):740\u2013756. https:\/\/doi.org\/10.1164\/rccm.202203-0490OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"12140_CR32","doi-asserted-by":"publisher","first-page":"e12051","DOI":"10.1002\/pul2.12051","volume":"12","author":"A Jose","year":"2022","unstructured":"Jose A, Apewokin S, Hussein WE, Ollberding NJ, Elwing JM, Haslam DB (2022) A unique gut microbiota signature in pulmonary arterial hypertension: A pilot study. Pulmonary circulation 12(1):e12051. https:\/\/doi.org\/10.1002\/pul2.12051","journal-title":"Pulmonary circulation"},{"issue":"1","key":"12140_CR33","doi-asserted-by":"publisher","first-page":"9681","DOI":"10.1038\/s41598-018-27682-w","volume":"8","author":"M Callejo","year":"2018","unstructured":"Callejo M, Mondejar-Parre\u00f1o G, Barreira B, Izquierdo-Garcia JL, Morales-Cano D, Esquivel-Ruiz S, Moreno L, Cogolludo \u00c1, Duarte J, Perez-Vizcaino F (2018) Pulmonary arterial hypertension affects the rat gut microbiome. Sci Rep 8(1):9681. https:\/\/doi.org\/10.1038\/s41598-018-27682-w","journal-title":"Sci Rep"},{"issue":"3","key":"12140_CR34","doi-asserted-by":"publisher","first-page":"204589402092914","DOI":"10.1177\/2045894020929147","volume":"10","author":"TJ Sanada","year":"2020","unstructured":"Sanada TJ, Hosomi K, Shoji H, Park J, Naito A, Ikubo Y, Yanagisawa A, Kobayashi T, Miwa H, Suda R, Sakao S, Mizuguchi K, Kunisawa J, Tanabe N, Tatsumi K (2020) Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416\/hypoxia rat model. Pulmonary circulation 10(3):2045894020929147. https:\/\/doi.org\/10.1177\/2045894020929147","journal-title":"Pulmonary circulation"},{"issue":"1","key":"12140_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/HYPERTENSIONAHA.120.14931","volume":"76","author":"RK Sharma","year":"2020","unstructured":"Sharma RK, Oliveira AC, Yang T, Karas MM, Li J, Lobaton GO, Aquino VP, Robles-Vera I, de Kloet AD, Krause EG, Bryant AJ, Verma A, Li Q, Richards EM, Raizada MK (2020) Gut pathology and its rescue by ACE2 (angiotensin-converting enzyme 2) in hypoxia-induced pulmonary hypertension. Hypertens (Dallas Tex : 1979) 76(1):206\u2013216. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.14931","journal-title":"Hypertens (Dallas Tex : 1979)"},{"issue":"1","key":"12140_CR36","doi-asserted-by":"publisher","first-page":"e12015","DOI":"10.1002\/pul2.12015","volume":"12","author":"AC Oliveira","year":"2022","unstructured":"Oliveira AC, Yang T, Li J, Sharma RK, Karas MK, Bryant AJ, de Kloet AD, Krause EG, Joe B, Richards EM, Raizada MK (2022) Fecal matter transplant from Ace2 overexpressing mice counteracts chronic hypoxia-induced pulmonary hypertension. Pulmonary circulation 12(1):e12015. https:\/\/doi.org\/10.1002\/pul2.12015","journal-title":"Pulmonary circulation"},{"issue":"8","key":"12140_CR37","doi-asserted-by":"publisher","first-page":"e1517","DOI":"10.1097\/TXD.0000000000001517","volume":"9","author":"EA Jasso-Baltazar","year":"2023","unstructured":"Jasso-Baltazar EA, Pe\u00f1a-Arellano GA, Aguirre-Valadez J, Ruiz I, Papacristofilou-Riebeling B, Jimenez JV, Garc\u00eda-Carrera CJ, Rivera-L\u00f3pez FE, Rodriguez-Andoney J, Lima-Lopez FC, Hern\u00e1ndez-Oropeza JL, D\u00edaz JAT, Kauffman-Ortega E, Ruiz-Manriquez J, Hern\u00e1ndez-Reyes P, Zamudio-Bautista J, Rodriguez-Osorio CA, Pulido T, Mu\u00f1oz-Mart\u00ednez S, Garc\u00eda-Ju\u00e1rez I (2023) Portopulmonary hypertension: an updated review. Transplantation direct 9(8):e1517. https:\/\/doi.org\/10.1097\/TXD.0000000000001517","journal-title":"Transplantation direct"},{"key":"12140_CR38","doi-asserted-by":"publisher","unstructured":"Savale, L., Guimas, M., Ebstein, N., Fertin, M., Jevnikar, M., Renard, S., Horeau-Langlard,D., Tromeur, C., Chabanne, C., Prevot, G., Chaouat, A., Moceri, P., Artaud-Macari,\u00c9., Degano, B., Tresorier, R., Boissin, C., Bouvaist, H., Simon, A. C., Riou, M.,Favrolt, N., \u2026 Sitbon, O. (2020). Portopulmonary hypertension in the current era of pulmonary hypertension management. Journal of hepatology, 73(1), 130\u2013139. https:\/\/doi.org\/10.1016\/j.jhep.2020.02.021","DOI":"10.1016\/j.jhep.2020.02.021"},{"issue":"2","key":"12140_CR39","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/microorganisms11020472","volume":"11","author":"L Luo","year":"2023","unstructured":"Luo L, Yin H, Gou D (2023) Gut microbiota and metabolome changes in three pulmonary hypertension rat models. Microorganisms 11(2):472. https:\/\/doi.org\/10.3390\/microorganisms11020472","journal-title":"Microorganisms"},{"issue":"11","key":"12140_CR40","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/hepr.14059","volume":"54","author":"K Tajima","year":"2024","unstructured":"Tajima K, Miuma S, Miyaaki H, Matsuo S, Shimakura A, Mori T, Takahashi K, Nakao Y, Fukushima M, Haraguchi M, Sasaki R, Ozawa E, Nakao K (2024) Total bile acids levels as a stratification tool for screening portopulmonary hypertension in patients with decompensated cirrhosis. Hepatol research: official J Japan Soc Hepatol 54(11):1049\u20131059. https:\/\/doi.org\/10.1111\/hepr.14059","journal-title":"Hepatol research: official J Japan Soc Hepatol"},{"issue":"6","key":"12140_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1165\/rcmb.2014-0438TR","volume":"52","author":"AC Swaminathan","year":"2015","unstructured":"Swaminathan AC, Dusek AC, McMahon TJ (2015) Treatment-related biomarkers in pulmonary hypertension. Am J Respir Cell Mol Biol 52(6):663\u2013673. https:\/\/doi.org\/10.1165\/rcmb.2014-0438TR","journal-title":"Am J Respir Cell Mol Biol"},{"key":"12140_CR42","doi-asserted-by":"publisher","unstructured":"Vignozzi L, Morelli A, Cellai I, Filippi S, Comeglio P, Sarchielli E, Maneschi E, Vannelli GB, Adorini L, Maggi M (2017) Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. J steroid Biochem Mol biology 165(Pt B) 277\u2013292. https:\/\/doi.org\/10.1016\/j.jsbmb.2016.07.004","DOI":"10.1016\/j.jsbmb.2016.07.004"},{"issue":"8","key":"12140_CR43","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40618-019-1009-2","volume":"42","author":"P Comeglio","year":"2019","unstructured":"Comeglio P, Filippi S, Sarchielli E, Morelli A, Cellai I, Corno C, Adorini L, Vannelli GB, Maggi M, Vignozzi L (2019) Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model. J Endocrinol Investig 42(8):951\u2013965. https:\/\/doi.org\/10.1007\/s40618-019-1009-2","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"12140_CR44","doi-asserted-by":"publisher","first-page":"L363","DOI":"10.1152\/ajplung.00212.2011","volume":"302","author":"JG Gomez-Arroyo","year":"2012","unstructured":"Gomez-Arroyo JG, Farkas L, Alhussaini AA, Farkas D, Kraskauskas D, Voelkel NF, Bogaard HJ (2012) The monocrotaline model of pulmonary hypertension in perspective. Am J Physiol Lung Cell Mol Physiol 302(4):L363\u2013L369. https:\/\/doi.org\/10.1152\/ajplung.00212.2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"12140_CR45","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.121.319971","volume":"130","author":"O Boucherat","year":"2022","unstructured":"Boucherat O, Agrawal V, Lawrie A, Bonnet S (2022) The latest in animal models of pulmonary hypertension and right ventricular failure. Circul Res 130(9):1466\u20131486. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.319971","journal-title":"Circul Res"},{"issue":"11","key":"12140_CR46","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1080\/13543784.2017.1385760","volume":"26","author":"P Comeglio","year":"2017","unstructured":"Comeglio P, Morelli A, Adorini L, Maggi M, Vignozzi L (2017) Beneficial effects of bile acid receptor agonists in pulmonary disease models. Expert Opin Investig Drugs 26(11):1215\u20131228. https:\/\/doi.org\/10.1080\/13543784.2017.1385760","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"12140_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/bph.15056","volume":"178","author":"L Harbaum","year":"2021","unstructured":"Harbaum L, Rhodes CJ, Otero-N\u00fa\u00f1ez P, Wharton J, Wilkins MR (2021) The application of \u2018omics\u2019 to pulmonary arterial hypertension. Br J Pharmacol 178(1):108\u2013120. https:\/\/doi.org\/10.1111\/bph.15056","journal-title":"Br J Pharmacol"},{"key":"12140_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fmed.2018.00157","volume":"5","author":"AR Hemnes","year":"2018","unstructured":"Hemnes AR (2018) Using omics to understand and treat pulmonary vascular disease. Front Med 5:157. https:\/\/doi.org\/10.3389\/fmed.2018.00157","journal-title":"Front Med"},{"key":"12140_CR49","doi-asserted-by":"publisher","unstructured":"Forbes, L. M., Bauer, N., Bhadra, A., Bogaard, H. J., Choudhary, G., Goss, K. N.,Gr\u00e4f, S., Heresi, G. A., Hopper, R. K., Jose, A., Kim, Y., Klouda, T., Lahm, T., Lawrie,A., Leary, P. J., Leopold, J. A., Oliveira, S. D., Prisco, S. Z., Rafikov, R., Rhodes,C. J., \u2026 Wilkins, M. R. (2025). Precision medicine for pulmonary vascular disease:the future is now (2023 grover conference series). Pulmonary circulation, 15(1), e70027. https:\/\/doi.org\/10.1002\/pul2.70027","DOI":"10.1002\/pul2.70027"},{"issue":"17","key":"12140_CR50","doi-asserted-by":"publisher","first-page":"13227","DOI":"10.3390\/ijms241713227","volume":"24","author":"PP Bassareo","year":"2023","unstructured":"Bassareo PP, D\u2019Alto M (2023) Metabolomics in pulmonary hypertension-a useful tool to provide insights into the dark side of a tricky pathology. Int J Mol Sci 24(17):13227. https:\/\/doi.org\/10.3390\/ijms241713227","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12140_CR51","doi-asserted-by":"publisher","first-page":"13284","DOI":"10.1038\/s41598-022-17374-x","volume":"12","author":"J Carlsen","year":"2022","unstructured":"Carlsen J, Henriksen HH, Marin de Mas I, Johansson PI (2022) An explorative metabolomic analysis of the endothelium in pulmonary hypertension. Sci Rep 12(1):13284. https:\/\/doi.org\/10.1038\/s41598-022-17374-x","journal-title":"Sci Rep"},{"issue":"4","key":"12140_CR52","doi-asserted-by":"publisher","first-page":"2301547","DOI":"10.1183\/13993003.01547-2023","volume":"62","author":"AM Andruska","year":"2023","unstructured":"Andruska AM, Zamanian RT (2023) Sorting the wheat from the chaff: the innovative case of precision transpulmonary metabolomics. Eur Respir J 62(4):2301547. https:\/\/doi.org\/10.1183\/13993003.01547-2023","journal-title":"Eur Respir J"},{"key":"12140_CR53","doi-asserted-by":"publisher","first-page":"115245","DOI":"10.1016\/j.bcp.2022.115245","volume":"204","author":"ADCU Ranasinghe","year":"2022","unstructured":"Ranasinghe ADCU, Schwarz MA (2022) Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension. Biochem Pharmacol 204:115245. https:\/\/doi.org\/10.1016\/j.bcp.2022.115245","journal-title":"Biochem Pharmacol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12140-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12140-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12140-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:39:32Z","timestamp":1781876372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12140-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12140"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12140-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Declaration\n                      of Generative AI Use\n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that no generative artificial intelligence tools were used in the writing of this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Declaration"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}],"article-number":"964"}}